This trial studies how well an online and mobile mindfulness intervention works in improving the well-being of cancer survivors. Many cancer survivors experience a range of side-effects after completing cancer treatment. An online and mobile mindfulness intervention may decrease anxiety and neuropathy and improve other aspects of well-being for cancer survivors.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03581357.
PRIMARY OBJECTIVES:
I. Evaluate the impact of mobile mindfulness on anxiety, pain, fatigue, trauma, and sleep (anxiety arm).
II. Evaluate the satisfaction with Mobile Mindfulness Meditation (anxiety arm).
III. Evaluate the impact of Mindfulness Coach on cancer related neuropathy anxiety, fatigue, and quality of life on people who are experiencing cancer related neuropathy as a result of treatment for cancer (neuropathy arm).
IV. Evaluate the satisfaction with Mindfulness Coach. Satisfaction with the intervention and potential differences in outcomes for people from differing age groups, cancer types, and ethnic groups will also be examined (neuropathy arm).
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive access to the Mobile Mindfulness Meditation application (app) and use the app for 8 weeks. Patients review 14 sessions via the app and practice mindfulness medication daily over 2 hour per week.
GROUP II: After 8 weeks, patients receive the access to the Mobile Mindfulness Meditation app, use it, and practice mindfulness medication as in Group I.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Hawaii Cancer Center
Principal InvestigatorErin O'Carroll Bantum
